Prise en charge de l'insomnie, 2017. ,
, L'électricité des songes, p.27, 2018.
Control of sleep and wakefulness in health and disease, Prog Mol Biol Transl Sci, pp.137-154, 2013. ,
Basal forebrain circuit for sleep-wake control, Nat Neurosci, pp.1641-1647, 2015. ,
Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat, J Neurosci Off J Soc Neurosci, pp.4705-4721, 1998. ,
GABA release in the dorsal raphe nucleus: role in the control of REM sleep, Am J Physiol, pp.451-455, 1997. ,
GABAergic parafacial zone is a medullary slow-wave-sleep promoting center, Nat Neurosci, pp.1217-1224, 2014. ,
Retino-hypothalamic regulation of lightinduced murine sleep, Front Syst Neurosci, p.135, 2014. ,
Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder, Brain J Neurol, pp.414-428, 2017. ,
Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle, J Neurosci Off J Soc Neurosci, vol.6716, issue.6720, 2005. ,
Neural substrates of awakening probed with optogenetic control of hypocretin neurons, 2007. ,
Bulletin de l'académie nationale de médecine, 2011. ,
, Dauvilliers. Insomnie. Encyclopédie Médico-Chirurgicale, 2004.
Exploration du sommeil chez l'adulte et l'adolescent Sleep investigations in adults and adolescents, 2004. ,
, Prise en charge du patient adulte se plaignant d'insomnie en médecine générale. Recommandations, SFTG -HAS, pp.5-27, 2006.
Hypersomnie et insomnie chez l'adulte, 2014. ,
Troubles du sommeil et de l'éveil : mise au point. La revue de médecine interne, pp.525-531, 2012. ,
European guideline for the diagnosis and treatment of insomnia, J Sleep Res, pp.675-700, 2017. ,
Chronic Insomnia Disorder: Contin Lifelong Learn Neurol, pp.1064-1092, 2017. ,
Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry. 100!112, 2005. ,
Gestion des hypnosédatifs en UCDG. Regroupement des unités de courte durée gériatriques et des services hospitaliers de gériatrie (RUSHGQ), 2017. ,
Du neuf et du moins neuf sur les insomnies du sujet dépressif, Médecine Sommeil, pp.12-22, 2006. ,
Insomnia with objective short sleep duration: The most biologically severe phenotype of the disorder, Sleep Med Rev, pp.241-54, 2013. ,
Troubles du sommeil de l'adulte et de l'adolescent, 2015. ,
Fasting activated histaminergic neurons and enhanced arousal effect of caffeine in mice, Pharmacol Biochem Behav, pp.164-173, 2015. ,
Le traitement de l'insomnie, 2010. ,
Chronic insomnia. The Lancet. 1129!1141, 2012. ,
Treatment of primary insomnia, J Am Board Fam Pract, pp.212-219, 2004. ,
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults, J Clin Sleep Med, pp.487-504, 2008. ,
Controversies in the use of second generation antipsychotics as sleep agent, Pharmacol Res, pp.1-8, 2014. ,
Efficacité de la thérapie comportementale et cognitive (TCCi) dans l'insomnie et dépression comorbide, 2017. ,
, Pharmacotherapy of Insomnia. J Cent Nerv Syst Dis, pp.1-7, 2018.
Making sleep easier: pharmacological interventions for insomnia, Expert Opin Pharmacother, pp.1465-1473, 2018. ,
, Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery, 2018.
Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines, CNS Spectr, pp.1027-1038, 2008. ,
Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications, Sleep Med Rev, pp.263-272, 2013. ,
Drugs for insomnia, Expert Opin Emerg Drugs, pp.299-317, 2012. ,
Bénéfices et inconvénients des hypnotiques, Neurophysiol Clin Neurophysiol, pp.245-265, 1991. ,
Treating insomnia: Current and investigational pharmacological approaches, Pharmacol Ther, pp.612-629, 2006. ,
Optimizing the Pharmacologic Treatment of Insomnia, Sleep Med Clin, vol.333, p.350, 2013. ,
Treatment of Benzodiazepine Dependence, N Engl J Med, 1147. ,
Plan d'actions de l'ANSM visant à réduire le mésusage des benzodiazépines, 2012. ,
Séance n°9 Commission des stupéfiants et psychotropes, 2014. ,
, ANSM. Lettre aux professionnels de santé : Zolpidem (Edluar®, Stilnox® et génériques): nouvelles conditions de prescription et délivrance, 2017.
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress, Nat Sci Sleep, p.81, 2016. ,
Suvorexant: a promising, novel treatment for insomnia, Neuropsychiatr Dis Treat, p.491, 2016. ,
Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists, Sleep, pp.33-42, 1999. ,
Sleep circuitry and the hypnotic mechanism of GABAA drugs, J Clin Sleep Med, pp.19-26, 2006. ,
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate, Hum Psychopharmacol, pp.13-20, 2008. ,
Hypothalamic regulation of sleep and circadian rhythms, Nature, 1257. ,
A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice, Sleep Med Rev. 265!, vol.274, 2009. ,
Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time, Nat Rev Drug Discov, vol.530, p.540, 2008. ,
Inhibition of [11C]-mirtazapine binding by ?2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain, 2006. ,
Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models, Eur J Pharmacol, pp.257-264, 2005. ,
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors, Nature, pp.542-546, 1995. ,
Deletion of the serotonin 2c receptor from transgenic mice overexpressing leptin does not affect their lipodystrophy but exacerbates their diet-induced obesity, Biochem Biophys Res Commun, pp.418-423, 2006. ,
The role of histamine and the tuberomamillary nucleus in the nervous system, Nat Rev Neurosci, pp.121-130, 2003. ,
Histamine in the Nervous System, Physiol Rev, pp.1183-1241, 2008. ,
Localization of histamine H4 receptors in the central nervous system of human and rat, Brain Res, pp.41-48, 2009. ,
Protein Selectivity Is Regulated by Multiple Intracellular Regions of GPCRs, Neurosignals, pp.1-12, 2003. ,
Histamine H1 receptors in human brain labelled with [3H]-Doxepin, Brain Res, pp.1-7, 1984. ,
A detailed mapping of hist amine H1-receptors in guinea-pig central nervous system established by autoradiography with, 1988. ,
Histamine H1 receptors in rat dorsal raphe nucleus: pharmacological characterisation and linking to increased neuronal activity, Brain Res, pp.247-55, 2002. ,
Histamine excites noradrenergic neurons in locus coeruleus in rats, Neuropharmacology, pp.129-134, 2005. ,
Cortical acetylcholine release elicited by stimulation of histamine H 1 receptors in the nucleus basalis magnocellularis: a dual-probe microdialysis study in the freely moving rat: Facilitation of acetylcholine release by histamine, Eur J Neurosci, pp.68-78, 2001. ,
Evidence for histaminergic arousal mechanisms in the hypothalamus of cat, 1988. ,
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor, Nature, pp.832-837, 1983. ,
Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness, Eur J Pharmacol, pp.283-287, 1991. ,
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders, Trends Pharmacol Sci, pp.618-625, 2004. ,
Orexin/Hypocretin Excites the Histaminergic Neurons of the Tuberomammillary Nucleus, J Neurosci, pp.9273-9279, 2001. ,
Glutamatergic regulation of histamine release from rat hypothalamus, Eur J Pharmacol, pp.189-192, 1992. ,
Serotonin excites tuberomammillary neurons by activation of Na+/Ca2+-exchange, Neuropharmacology, pp.345-351, 2001. ,
Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat, J Neurosci, pp.1523-1537, 1996. ,
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice, Proc Natl Acad Sci, pp.4687-4692, 2006. ,
Hypothalamo-preoptic Histaminergic Projections in Sleep-Wake Control in the Cat, Eur J Neurosci, pp.618-625, 1994. ,
Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats, Behav Brain Res, pp.271-278, 2004. ,
Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current, Neuroscience, pp.579-588, 1994. ,
Microinjection of the melaninconcentrating hormone into the lateral basal forebrain increases REM sleep and reduces wakefulness in the rat, Life Sci, pp.895-899, 2012. ,
An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons, 2001. ,
Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state, Behav Brain Res, pp.183-204, 2000. ,
Adenosine and the homeostatic control of sleep: Effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness, 2008. ,
Diurnal variations in brain and pituitary histamine and histamine-N-methyltransferase in the rat and guinea pig, Med Biol, pp.204-209, 1982. ,
Anatomical, Physiological, and Pharmacological Characteristics of Histidine Decarboxylase Knock-Out Mice: Evidence for the Role of Brain Histamine in Behavioral and Sleep-Wake Control, J Neurosci, pp.7695-7711, 2002. ,
Circadian Release of Hypothalamic Norepinephrine in Rats In Vivo Is Depressed during Early L-Lysine Deficiency, J Nutr, pp.1641-1643, 2000. ,
Circadian 5-HT production regulated by adrenergic signaling, Proc Natl Acad Sci, pp.4686-4691, 2002. ,
Quantitative microdialysis of dopamine in the striatum: effect of circadian variation, J Neurosci Methods, pp.33-41, 1992. ,
Release of Hypocretin (Orexin) during Waking and Sleep States, J Neurosci, pp.5282-5286, 2002. ,
Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects, Biol Psychiatry, pp.96-104, 2003. ,
Circadian and Homeostatic Regulation of Hypocretin in a Primate Model: Implications for the Consolidation of Wakefulness, J Neurosci, pp.3555-3560, 2003. ,
Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis, Psychopharmacology (Berl), pp.393-400, 1999. ,
A Critical Review of 5-HT Brain Microdialysis and Behavior, Rev Neurosci, pp.117-137, 1997. ,
Hypocretins in the Control of Sleep and Wakefulness, Curr Neurol Neurosci Rep, pp.174-179, 2010. ,
Effects of 2-Week Treatment With Temazepam and Diphenhydramine in Elderly Insomniacs: A Randomized, Placebo-Controlled Trial, J Clin Psychopharmacol, pp.182-188, 2008. ,
Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial, 2005. ,
Tolerance to daytime sedative effects of H1 antihistamines, J Clin Psychopharmacol, pp.511-515, 2002. ,
Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study, J Clin Psychiatry, pp.453-463, 2001. ,
Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study, 2002. ,
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia, 2007. ,
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study, J Clin Psychiatry, pp.1557-1564, 2008. ,
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia, pp.1553-1561, 2010. ,
Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia, pp.1433-1442, 2011. ,
Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients, Am J Geriatr Psychiatry, pp.44-57, 2008. ,
A polysomnography study of eszopiclone in elderly patients with insomnia, Curr Med Res Opin, pp.1633-1642, 2006. ,
Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety, Int J Psychiatry Clin Pract, pp.161-168, 2014. ,
Histamine and antihistamines, Anaesth Intensive Care Med, pp.324-329, 2011. ,
Antihistaminergics and inverse agonism: Potential therapeutic applications, Eur J Pharmacol, pp.26-32, 2013. ,
H1 Antihistamines: Current Status and Future Directions, World Allergy Organ J, pp.145-55, 2008. ,
Advances in H1-Antihistamines, N Engl J Med, 2004. ,
Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults : Recommendations of a Gerontological Society of America Workgroup. The Gerontologist, pp.163-170, 2015. ,
Médicaments et risque de glaucome par fermeture de l'angle, J Fr Ophtalmol, pp.91-101, 2002. ,
Histamine-1 receptor antagonism for treatment of insomnia, J Am Pharm Assoc, pp.210-219, 2012. ,
Toxicité aiguë de la doxylamine. Revue bibliographique, Toxicol Anal Clin, pp.261-270, 2016. ,
The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection, J Clin Pharmacol, pp.448-451, 1985. ,
The associative factors of delayed-onset rhabdomyolysis in patients with doxylamine overdose, Am J Emerg Med, pp.903-907, 2011. ,
Clearance of the Antihistamine Doxylamine: Reduced in Elderly Men But Not in Elderly Women, Clin Pharmacokinet, pp.312-316, 1989. ,
Effects of doxylamine and acetaminophen on postoperative sleep, Clin Pharmacol Ther, pp.549-557, 1985. ,
The hypnotic efficacy of doxylamine, Clin Pharmacol Ther, pp.48-54, 1967. ,
Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France, PLoS ONE, p.76499, 2013. ,
, Alpha-bloquants et anticholinergiques chez le sujet âgé : comment prescrire ? Prog En Urol -FMC, 9!13, 2015.
Échelles d'évaluation de l'effet anticholinergique des médicaments, NPG Neurol -Psychiatr, 2012. ,
Syndrome of inappropriate antidiuresis in doxylamine overdose. Case Rep, p.7428, 2012. ,
Benzo-and thienobenzo-diazepines: multi-target drugs for CNS disorders, Mini Rev Med Chem, pp.630-647, 2015. ,
Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study: ANTICHOLINERGIC ACTIVITY AND COGNITION, J Am Geriatr Soc, pp.1477-1483, 2011. ,
Suicide through doxylamine poisoning, Forensic Sci Int, 2001. ,
Retrospective review of unintentional pediatric ingestions of doxylamine, Clin Toxicol, pp.178-180, 2015. ,
, ANSM. DONORMYL 15 mg, comprimé pelliculé sécable -Résumé des caractéristiques du produit
, , p.6, 2018.
,
Rhabdomyolysis in doxylamine overdose, Lancet Lond Engl, pp.442-443, 1987. ,
Rhabdomyolysis Complicating Doxylamine Overdose, Clin Pediatr (Phila, pp.595-597, 1987. ,
Unique binding pocket for KW-4679 in the histamine H1 receptor, Eur J Pharmacol, pp.111-117, 1998. ,
Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians, Int J Mol Sci, p.50, 2015. ,
Bilastine vs. hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers, Br J Clin Pharmacol, pp.970-980, 2014. ,
intérêt de la Santé publique ma profession avec conscience et de respecter non seulement la législation en vigueur mais aussi les règles de l'Honneur ,
, De ne jamais oublier ma responsabilité et mes devoirs envers le malade et sa dignité humaine
, De ne dévoiler à personne les secrets qui m'auraient été confiés ou dont j'aurais eu connaissance dans l'exercice de ma Profession
, En aucun cas, je ne consentirai à utiliser mes connaissances et mon état pour corrompre les moeurs et favoriser les actes criminels
, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses. Que je sois méprisé de mes Confrères si je manque à mes engagements
, &,01)2+,-34/&+34)5)/4+,)3)6
, ! (.@(,-5.! 5?-:9, vol.5, p.5
,
,
, , p.9
,
, , vol.9
,
, D<-?.:!.HH9<'<.:!)'9:!.N5
, , p.9
, ;')9/9A-.:!)'?@(D!?.:!H'9C?.:!>,:.:!-;9?9:D.:$!7.!H'9
, !>9)9/-.!?.!(9:A-.!>8'55, vol.9
, D<-?.:*!
, ! >9), vol.9
, 9<#
,
,
, , vol.5
,
, , vol.9
, @9.!